The research collected data from 2,326 participants over the course of two RSV seasons between 2019 and 2021. Due to its timing aligning with the pandemic, the physicians suggest the study may be the first of its kind to assess “the incidence of RSV-positive ARI before and during the COVID-19 pandemic and the short- and long term outcomes of RSV-positive ARI in adults 50 years or older in the United States.”
Their extensive research revealed that RSV-positive acute respiratory infections were found to be “associated with significant long-term impacts on health-related [quality of life] beyond the acute infection in adults over 50.”
Importantly, the results of the study pointed out that the significant effects on long-term quality of life after RSV infection were independent of other factors such as race, sex and ethnicity.
In their conclusion, the physicians suggested that further research into “an effective RSV vaccine might be an important measure to mitigate the impact of RSV-positive ARI, especially in older adults.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
